Oruka Therapeutics, Inc.
ORKA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $61,575 | $37,431 | $42,445 | $53,359 |
| Short-Term Investments | $314,073 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1,221 | $161 | $254 | $1,062 |
| Total Curr. Assets | $376,869 | $37,592 | $42,699 | $54,421 |
| Property Plant & Equip (Net) | $1,038 | $257 | $368 | $485 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $18,069 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $43 | $12 | $18 | $18 |
| Total NC Assets | $19,150 | $269 | $386 | $503 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $396,019 | $37,861 | $43,085 | $54,924 |
| Liabilities | – | – | – | – |
| Payables | $3,462 | $0 | $334 | $1,117 |
| Short-Term Debt | $213 | $76 | $103 | $100 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $7,327 | $461 | $522 | $1,356 |
| Total Curr. Liab. | $13,043 | $637 | $1,132 | $3,498 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $755 | $204 | $280 | $383 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $968 | $0 | $0 | $0 |
| Total Liabilities | $13,798 | $841 | $1,412 | $3,881 |
| Equity | – | – | – | – |
| Pref Stock | $2,931 | $0 | $0 | $0 |
| Common Stock | $37 | $14 | $14 | $14 |
| Retained Earnings | -$83,724 | -$188,741 | -$183,402 | -$173,476 |
| AOCI | -$41 | $0 | $0 | $0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $382,221 | $37,020 | $41,673 | $51,043 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $396,019 | $37,861 | $43,085 | $54,924 |
| Net Debt | -$61,362 | -$37,355 | -$42,342 | -$53,259 |